Table 2 Patients with < 50% of predicted forced expiratory volume in 1 s (FEV₁), in both the Swedish National Airway Register (SNAR) and the Swedish Register of Palliative Care (SRPC) (n = 598), categorized by place of death, i.e., specialized palliative care (SPC) versus hospital. Independent samples t-test was used for continuous variables and Fisher’s exact test for categorical variables

Mean (SD)

Mean (SD)

Time between last registered visit^a and death, days

682.2 (540.1)

612.2 (488.4)

Number of days in the care setting

Median (min, max)

44.8 (82.6)

12 (min 1, max 493)

8.37 (9.9)

5 (min 1, max 102)

Demographic variables

 Age, years

73.5 (7.7)

75.3 (7.3)

n (%)

n (%)

 Sex:

  Men

  Women

87 (54.7%)

72 (45.3%)

195 (44.4%)

244 (55.6%)

 Living situation:

  Living alone

  Cohabiting

26 (34.2%)

50 (65.8%)

91 (47.6%)

100 (52.4%)

Clinical variables

Mean (SD)

Mean (SD)

Number of exacerbations in the last 12 months

1.7 (2.4)

1.3 (1.9)

Number of hospitalizations in the last 12 months

0.7 (1.4)

0.7 (1.5)

FEV₁% predicted

32.5 (9.3)

33.0 (9.6)

Exercise capacity (days/week)

2.0 (2.6)

2.1 (2.6)

Patient-reported variables

n (%)

n (%)

Smoking:

 Non-smokers

 Ex-smokers

 Still smoking

6 (3.8%)

101 (64.3%)

50 (31.8%)

18 (4.2%)

308 (71.3%)

106 (24.5%)

Mean (SD)

Mean (SD)

Dyspnea (mMRC)

2.99 (1.1)

2.89 (1.1)

HRQoL (CCQ)

2.59 (1.2) (n = 84)

2.55 (1.1) (n = 182)

HRQoL (CAT)

20.4 (7.4) (n = 30)

19.95 (7.8) (n = 124)

Comorbidity

n (%)

n (%)

Heart failure

16 (12.6%)

93 (28.4%)

Ischemic heart disease

29 (22.5%)

101 (31.1%)

Stroke

9 (8.7%)

21 (8.3%)

Hypertension

59 (43.7%)

190 (55.6%)

Diabetes

21 (15.2%)

46 (13.3%)

Osteoporosis

22 (18.2%)

70 (24.8%)

Depression/anxiety

32 (23.7%)

64 (19.4%)

Lung cancer

8 (7.4%)

7 (2.4%)

Alpha-1 antitrypsin deficiency

2 (2.0%)

4 (1.5%)